Avingtrans upgrades FY25 outlook with stronger EBITDA performance

Avingtrans plc

Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced an update on current trading ahead of conclusion of the financial year ending 31 May 2025.

Based on unaudited management accounts for FY25, the Company now expects to report Adj. EBITDA¹ ahead of market expectations², driven by better than anticipated performance within the Advanced Engineering Systems (AES) division. Revenues are expected to be in-line2.

Avingtrans intends to provide a more detailed update on current performance by way of a trading update to be published in mid June 2025.

¹Adjusted to add back amortisation of intangibles from business combinations, acquisition costs and exceptional items and discontinued operations.

² Prior to today’s announcement, the Company understands that market expectations for FY25 were Revenues of £161.0m and

Adj. EBITDA of £15.1m.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Avingtrans Raises £21 Million to Expand Its US Nuclear Opportunity, Cavendish

Avingtrans secures £21 million to expand US nuclear capacity, supporting forecast growth, stronger margins and Cavendish’s increased target price outlook.

Avingtrans launches proposed placing to support corporate funding

Avingtrans plc has announced a proposed placing, with the announcement initially accompanied by standard securities offering disclaimers.

Booth Industries builds rail infrastructure credibility with HS1 safety systems

Booth Industries’ HS1 project shows its ability to deliver certified safety systems for critical rail infrastructure with long-term reliability.

Avingtrans reports FY26 profit in line with expectations

Avingtrans says profit for the year will be in line with expectations, with further contract wins across nuclear, infrastructure and imaging markets.

UK quantum strategy highlights opportunity for specialist magnet systems

UK plans to scale quantum computing highlight the role of specialist superconducting magnet systems in supporting the sector’s move towards commercial deployment.

Adaptix gains market access milestone with Ortho350 certification

Adaptix has secured CE certification for Ortho350, giving the company a clearer route into UK and European orthopaedic imaging markets.

Search